Sickle Cell Disease Clinical Trials in Phoenix, Arizona
6 studies are recruiting for sickle cell disease in Phoenix, Arizona right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
Etavopivat is a new medicine under development for treating blood disorders like sickle cell disease and thalassaemia. Sickle cell disease and thalassaemia are inherited blood disorders that affect haemoglobin. Haemoglobin is the protein that carries oxygen through the body. This study is looking i…
- Stage
- Phase 3
- Ages
- 2 and older
- Site
- Phoenix Children's Hsptl, Phoenix, Arizona
- Locations
- 107 in total
- Run by
- Novo Nordisk A/S
-
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
This study is conducted to confirm whether etavopivat works well at reducing the number of Vaso-occlusive crisis VOCs (sickle cell pain crises) caused by obstructions in blood vessels in adults and adolescents living with sickle cell disease. The study will also evaluate how well etavopivat can red…
- Stage
- Phase 3
- Ages
- 12 and older
- Site
- Phoenix Children's Hsptl, Phoenix, Arizona
- Locations
- 175 in total
- Run by
- Novo Nordisk A/S
-
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
In parallel with the growth of ATHN's clinical studies, the number of new therapies for all blood disorders is increasing significantly. Some of the recently FDA-approved therapies for congenital and acquired hematologic conditions have not yet demonstrated long-term safety and effectiveness beyond…
- Stage
- Not phased
- Ages
- Any age
- Site
- Arizona Hemophilia and Thrombosis Treatment Center at Phoenix Children's Hospital, Phoenix, Arizona
- Locations
- 76 in total
- Run by
- American Thrombosis and Hemostasis Network
-
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, flexible-adaptive, group-sequential study (Part A), followed by an open-label LTE period (Part B) to investigate the efficacy, and safety of rilzabrutinib in participants with sickle-cell disease (SCD). Study detai…
- Stage
- Phase 3
- Ages
- 10 to 65
- Site
- Phoenix Children's Hospital- Site Number : 8400028, Phoenix, Arizona
- Locations
- 53 in total
- Run by
- Sanofi
-
A Long-term Follow-up Study in Patients Who Received BEAM-101
This is a Long-term Follow-up (LTFU) study in patients who received BEAM-101 in the parent study (Study BTX-AUT-001). Eligible patients who received BEAM-101 will be asked to participate in this LTFU study prior to completing Study BTX-AUT-001. Patients who enter into this study will be followed fo…
- Stage
- Not phased
- Ages
- 14 to 37
- Site
- Phoenix Children's Hospital, Phoenix, Arizona
- Locations
- 17 in total
- Run by
- Beam Therapeutics Inc.
-
Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
The goal of this observational study is to help us understand more about the best ways to help individuals living with Sickle Cell Disease (SCD) get the best care. The main question it aims to answer is: How to find individuals unaffiliated from SCD specialist care use three distinct pathways? Once…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Phoenix Children's Hospital, Phoenix, Arizona
- Locations
- 9 in total
- Run by
- RTI International
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.